3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Liver Diseases
1
Liver Cirrhosis
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
Sorafenib
42
Bevacizumab
16
Oxaliplatin
13
Radiosurgery
10
Gemcitabine
10
Doxorubicin
10
Capecitabine
10
Leucovorin
9
Hepatectomy
9
Fluorouracil
9
Cisplatin
9
Radiofrequency Ablation
8
Nivolumab
8
pembrolizumab
7
Drug Therapy
7
Carboplatin
7
Irinotecan
6
Cryosurgery
6
Talaporfin
5
Mitomycin
5
Everolimus
5
Erlotinib Hydrochloride
5
Electroporation
5
spartalizumab
4
Sunitinib
4
Melphalan
4
Ipilimumab
4
Epirubicin
4
Embolization, Therapeutic
4
regorafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Liver Neoplasms
×
Shadowing Technique, Histology
×
Clear all
NCT03405909
2021-03-02
ESCULAP
University Hospital Erlangen
Completed
517 enrolled